Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Nov 06, 2024 3:18pm
102 Views
Post# 36299468

RE:RE:RE:RE:Get ready for the Trump “carnage”….

RE:RE:RE:RE:Get ready for the Trump “carnage”….Hey, Bucky , I know hard for you to comprehend with your grade 5 education.
Simple look all USA indexes are up.
All Canadian indexes are down.
asside from that.....
ONC Will only show it# potential value if/ when a partnership and/ or a buyout is announced.
The USA indexes are reacting to the solid results.
ONC on their web page ( does require reading) give clear guidance on potential future income from Pela .
That being $2.5 billion/ year.
As of today, they still need to announce a potential partnership/ license for the MBc trial to proceed.
Then & only then will we see the real worth of Onc.
in the wait, I could care less if the price goes up or Down.
I actually bought a small 2k additional shares yesterday.
With an analyst consensus of " buy" & targets of $5 average.
lots of upside.
They never include buyout targets as that is pure speculation.
analysts use " net present value " of future earnings, with huge discounts for risk.
Sorry Bucky for all the words. I'm aware you have a comprehension disability.
maybe someday you can get back to school.

<< Previous
Bullboard Posts
Next >>